Home > Insider Trading > Filing (0001415889-24-028899)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1870404	Cero Therapeutics Holdings Inc.	CERO	Biological Products, (No Disgnostic Substances) (2836)	871088814

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
2042634	Yk Bioventures Opportunities Gp I, Llc	398 Primrose Road, Suite 328 Burlingame CA 94010	No	No	No	No
2042636	Yk Bioventures Opportunities Fund I, L.p.	398 Primrose Road, Suite 328 Burlingame CA 94010	No	No	Yes	No
2042691	William Mitchell Kossar	C/O Yk Bioventures 398 Primrose Road, Suite 328 Burlingame CA 94010	No	No	Yes	No
2042700	Kahing Gary Yeung	C/O Yk Bioventures 398 Primrose Road, Suite 328 Burlingame CA 94010	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-12-06	1,236,874	$0.12	21,383,909	No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.
Common Stock	Disposition	2024-12-09	850,543	$0.11	20,533,366	No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.
Common Stock	Disposition	2024-12-10	1,570,947	$0.09	18,962,419	No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.
No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.
No	4	S	Indirect	By YK Bioventures Opportunities Fund I, L.P.

Footnotes

Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.